中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
H-β-(2-吡啶)-DL-Ala-OH |
2-amino-3-(pyridin-2-yl)propanoic acid |
17407-44-2 |
C8H10N2O2 |
|
H-SER(TBU)-甲氧基盐酸盐 |
O-tert-butyl-L-serine methyl ester |
17083-26-0 |
C8H17NO3 |
|
H-Orn(Z)-OtBu 盐酸盐 |
H-Orn(Cbz)-OtBu hydrochloride |
161234-80-6 |
C17H26N2O4*ClH |
|
G蛋白拮抗剂肽 |
G Protein Antagonist |
143675-79-0 |
C57H64N12O9S |
|
Gona-1,5,7,9,11,13-hexaen-17-one,3,4-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-,(3a,4b)-(?脿)- |
3,4,15,16-tetrahydro-trans-3,4-bis<(tert-butyldimethylsilyl)oxy>cyclopenta<a>phenanthren-17-one |
143216-83-5 |
C29H42O3Si2 |
|
Givinostat盐酸盐 |
diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride |
199657-29-9 |
C24H27N3O4*ClH |
|
GinsenoyneK;(3R,10S,8E)-10-氢过氧-1,8-十七碳二烯-4,6-二炔-3-醇 |
(3R,8E,10S)-10-Hydroperoxyheptadeca-1,8-dien-4,6-diyn-3-OL |
141947-42-4 |
C17H24O3 |
|
Garg5-溴-3,4-吡啶炔前体 |
5-bromo-4-(trimethylsilyl)pyridin-3-yl triflate |
1413439-82-3 |
C9H11BrF3NO3SSi |
|
Gardenine;[2aS-(2aalpha,4aalpha,7aalpha,7balpha)]-2,2a,4a,7,7a,7b-六氢-2a-羟基-1-氧杂-7-氮杂环戊并[cd]茚-5-羧酸甲酯 |
Gardenine |
139682-36-3 |
C11H13NO4 |
|
Gamma-L-谷氨酰-Beta-萘酰胺 |
(S)-2-Amino-5-(naphthalen-2-ylamino)-5-oxopentanoic acid |
14525-44-1 |
C15H16N2O3 |
|
GZD824甲磺酸盐 |
GZD824 Dimesylate |
1421783-64-3 |
C31H35F3N6O7S2 |
|
GYKI52466,盐酸盐 |
GYKI 52466 hydrochloride |
192065-56-8 |
C17H16ClN3O2 |
|
GYKI-53655水合物 |
5-(4-aminophenyl)-N,8-dimethyl-8,9-dihydro-[1,3]dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide;hydron;chloride |
143692-48-2 |
C19H21ClN4O3 |
|
GW405833盐酸盐 |
(2,3-dichlorophenyl)(5-methoxy-2-methyl-3-(2-morpholinoethyl)-1H-indol-1-yl)methanone |
180002-83-9 |
C23H24Cl2N2O3 |
|
GSKPERK抑制剂 |
1-[5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1H-indol-1-yl]-2-[3-fluoro-5-(trifluoromethyl)phenyl]ethanone |
1337531-89-1 |
C24H19F4N5O |
|
GSK789472盐酸盐 |
1-Phenyl-3-(piperidin-2-ylmethyl)imidazolidin-2-one hydrochloride |
1257326-24-1 |
C15H22ClN3O |
|
GSK2636771甲酯 |
methyl 2-methyl-1-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylate |
1372540-24-3 |
C23H24F3N3O3 |
|
GSK256066三氟乙酸盐 |
GSK256066 2,2,2-trifluoroacetic acid |
1415560-64-3 |
C29H27F3N4O7S |
|
GSK2334470游离态 |
GKS2334470 |
1227911-45-6 |
C25H34N8O |
|
GSK2193874游离态 |
GSK2193874 |
1336960-13-4 |
C37H38BrF3N4O |
|
GSK-2110183C无结构图 |
afuresertib |
1047644-62-1 |
C18H17Cl2FN4OS |
|
GSK 525762A; (4S)-6-(4-氯苯基)-N-乙基-8-甲氧基-1-甲基-4H-[1,2,4]三唑并[4,3-a][1,4]苯并二氮杂卓-4-乙酰胺 |
I-BET762 |
1260907-17-2 |
C22H22ClN5O2 |
|
GSK 1292263 盐酸盐 |
5-[({1-[3-(1-Methylethyl)-1,2,4-oxadiazol-5-yl]-4-piperidinyl}methyl)oxy]-2-[4-(methylsulfonyl)phenyl]pyridine hydrochloride |
1032824-54-6 |
C23H28N4O4S*ClH |
|
GR 127935盐酸盐 |
N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-carboxamide |
148672-13-3 |
C29H31N5O3 |
|
GNF179代谢物 |
2-(4-Fluorophenyl)-8,8-dimethyl-5,6,7,8-tetrahydroimidazo[1,2-A]pyrazine |
1310455-86-7 |
C14H16FN3 |
|
GNE-495游离态 |
8-amino-N-(1-(cyclopropanecarbonyl)azetidin-3-yl)-2-(3-fluorophenyl)-1,7-naphthyridine-5-carboxamide |
1449277-10-4 |
C22H20FN5O2 |
|
GNE-477抑制剂 |
GNE-477 |
1032754-81-6 |
C21H28N8O3S2 |
|
GNE-0877抑制剂 |
2-methyl-2-(3-methyl-4-((4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)-1H-pyrazol-1-yl)propanenitrile |
1374828-69-9 |
C14H16F3N7 |
|
GLYX13抑制剂 |
Glyx-13 |
117928-94-6 |
C18H31N5O6 |
|
GLPG0187,一种广谱的INTEGRIN受体拮抗剂,具有抗肿瘤活性 |
L-Alanine, 3-((2,5-dimethyl-6-(4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-1-piperidinyl)-4-pyrimidinyl)amino)-N-((4-methoxyphenyl)sulfonyl) |
1320346-97-1 |
C29H37N7O5S |
|
GLPG-0634 中间体 |
N-(5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide |
1142943-96-1 |
C10H9BrN4O |
|
GJ103游离 |
2-((4-(3-methoxyphenyl)-5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid |
1459687-89-8 |
C16H14N4O3S |
|
GJ-103钠盐 |
sodium 2-((4-(3-methoxyphenyl)-5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetate |
1459687-96-7 |
C16H13N4O3S*Na |
|
GDC-0349; N-Ethyl-N'-[4-[5,6,7,8-四氢-4-[(3S)-3-甲基-4-吗啉基]-7-(3-氧杂环丁基)吡啶并[3,4-d]嘧啶-2-基]苯基]脲 |
(S)-1-ethyl-3-(4-(4-(3-methylmorpholino)-7-(oxetan-3-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-yl)phenyl)urea |
1207360-89-1 |
C24H32N6O3 |
|
GD-6肽 |
7,8,9-Trihydroxy-7,8,9,10-tetrahydrobenzo(a)pyrene-10-sulfonate |
124443-16-9 |
C20H16O6S |
|
GC-R2醚化物 |
N,N'-bis(2,6-diisopropylphenyl)-1,6,7,12-tetraphenoxy perylene-3,4:9,10-tetracarboxylic acid diimide |
123174-58-3 |
C72H58N2O8 |
|
G9A和PRC2抑制剂(BRD9539) |
2-benzamido-1-(3-phenylpropyl)-1H-1,3-benzodiazole-5-carboxylic acid |
1374601-41-8 |
C24H21N3O3 |
|
G-418 硫酸盐 |
geneticin sulfate |
108321-42-2 |
C20H40N4O10*H2O4S |
|
Fragransin A2; 4,4'-[(2R,3R,4R,5R)-四氢-3,4-二甲基-2,5-呋喃基]双[2-甲氧基苯酚] |
(+)-fragransin A2 |
112652-46-7 |
C20H24O5 |
|
Fmoc-(S)-3-氨基-3-(2-呋喃基)丙酸 |
Fmoc-(S)-3-amino-3-(2-furyl)-propionic acid |
1217741-88-2 |
C22H19NO5 |
|
Fmoc-(S)-3-噻吩基甘氨酸 |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(thiophen-3-yl)acetic acid |
1217706-09-6 |
C21H17NO4S |
|
Fmoc-(R)-3-氨基-4-(2,4,5-三氟苯基)丁酸 |
(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid |
1217818-53-5 |
C25H20F3NO4 |
|
Fmoc-(R)-2-(氨基甲基)-4-甲基戊酸 |
Fmoc-(R)-β<sup>2</sup>hLeu-OH |
1018899-99-4 |
C22H25NO4 |
|
Fmoc-(R)-2-甲氧基苯基甘氨酸 |
(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(2-methoxyphenyl)acetic acid |
1217838-25-9 |
C24H21NO5 |
|
Fmoc-肌氨酸五氟苯酯 |
N-[N-(fluoren-9-ylmethoxycarbonyl)-N-methylglycyl]pentafluorophenyl ester |
159631-29-5 |
C24H16F5NO4 |
|
Fmoc-缬氨醇 |
2-[(S)-(fluoren-9-ylmethoxycarbonyl)amino]-3-methylbutan-1-ol |
160885-98-3 |
C20H23NO3 |
|
Fmoc-环戊基-D-Gly-OH |
(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-cyclopentylacetic acid |
136555-16-3 |
C22H23NO4 |
|
Fmoc-环亮氨酸 |
1-(9H-fluoren-9-ylmethoxycarbonylamino)-cyclopentanecarboxylic acid |
117322-30-2 |
C21H21NO4 |
|
Fmoc-异硫氰酸 |
9-fluorenylmethoxycarbonyl isothiocyanate |
199915-38-3 |
C16H11NO2S |
|
Fmoc-异leucinol |
Fmoc-Ile-ol |
133565-46-5 |
C21H25NO3 |
|